Ventas, Inc. VTR
Real Estate · REIT - Healthcare Facilities · United States · S&P 500
Based on the available data, Ventas, Inc. gets an algorithmic score of 41/100. It trades at 86.91 $, with a bullish technical trend (RSI 36.1) and 22.2% annual volatility.
Updated: 2026-09-30
Open in the interactive tool →
Strengths
- Sustained revenue growth (12.2% compound annual).
- Low beta (0.27): defensive profile.
Weaknesses
- Low ROE (2.0%).
- Demanding valuation (P/E 110.0): the market prices in a lot of growth.
Fundamentals
| P/E | 158.02 |
| Forward P/E | 110.01 |
| PEG | 4.94 |
| P/B | 3.04 |
| EV/EBITDA | 24.30 |
| P/S | 6.95 |
| ROE % | 2.01 |
| ROA % | 2.17 |
| Gross margin % | 39.97 |
| Operating margin % | 14.81 |
| Net margin % | 4.09 |
| Revenue growth % (y/y) | 21.70 |
| Earnings growth % (y/y) | -6.70 |
| Revenue CAGR % | 12.21 |
| Debt/Equity % | 84.93 |
| Current ratio | 0.29 |
| FCF yield % | 2.25 |
| Dividend yield % | 2.39 |
| Payout % | 363.64 |
Returns
| 1 month | -5.3 % |
| 3 months | -2.1 % |
| 6 months | +7.8 % |
| YTD | +13.8 % |
| 1 year | +29.2 % |
| 3 years | +124.2 % |
| 5 years | +82.3 % |
Risk
| 1-year volatility | 22.2 % |
| Beta | 0.27 |
| 5-year max drawdown | -41.8 % |
| Sharpe 1A | 1.09 |
Macroeconomic context
Highly sensitive to mortgage and funding rates. Falling rates revalue assets; occupancy is tied to employment and the cycle. As a US company, its valuation depends on the Fed, 10-year Treasury yields and the US earnings cycle.
How the score is calculated
The score combines profitability (ROE, ROA, net margin), growth (revenue and earnings), valuation (P/E, EV/EBITDA, free cash flow), financial strength (debt and liquidity; not applied to banks and insurers) and momentum (6 and 12-month returns and trend). It is an educational quantitative filter, not a buy or sell recommendation.